lisdexamfetamine dimesilate - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
| Product details |
Supply Impact Dates |
Further Details |
VYVANSE lisdexamfetamine dimesilate 30mg capsule bottle AUST R: 199227Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
07 Aug 2023
to
07 Mar 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
Emergency Supply of VYVANSE lisdexamfetamine dimesilate 30mg capsule bottle AUST R: 199227 is available from the sponsor. Please contact Takeda Pharmaceuticals Australia Pty Ltd on 1800 012 612 or medinfoapac@takeda.com for details on supply.
An unregistered product has also been approved for supply under Section 19A.The approval holder, Medsurge can be contacted for details on supply on: 1300 788 261 or sales@medsurge.com.au
|
VYVANSE lisdexamfetamine dimesilate 50mg capsule bottle AUST R: 199226Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
03 Nov 2023
to
07 Mar 2024
|
Shortage status:
Current
Availability:
Limited Availability
Reason:
Manufacturing
Management action:
The sponsor is closely controlling the supply and working to expedite the next shipment.
Emergency Supply of VYVANSE lisdexamfetamine dimesilate 50mg capsule bottle AUST R: 199226 is available from the sponsor. Please contact Takeda Pharmaceuticals Australia Pty Ltd on 1800 012 612 or medinfoapac@takeda.com for details on supply.
|
VYVANSE lisdexamfetamine dimesilate 60 mg capsules bottle AUST R: 284021Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
18 Dec 2023
to
19 Apr 2024
|
Shortage status:
Anticipated
Availability:
Available
Reason:
Manufacturing
Management action:
The sponsor is closely controlling the supply and working to expedite the next shipment
|
VYVANSE lisdexamfetamine dimesilate 20 mg capsules bottle AUST R: 284019Active ingredients:
lisdexamfetamine dimesilate
Dosage form:
Capsule, hard
Sponsor:
Takeda Pharmaceuticals Australia Pty Ltd
Phone:
1800012612
|
From
09 Oct 2023
to
09 Oct 2023
|
Shortage status:
Resolved
Availability:
Available
Reason:
Manufacturing
|